22:53:17 EDT Wed 02 Jul 2025
Enter Symbol
or Name
USA
CA



E:CYBN - CYBIN INC. - https://www.cybin.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CYBN - E  1.09.93·10.251.09.98-1.42-12.534.437236312.18  12.20  9.9519.46  6.9516:00:00Jul 0115 min
NEO exchange - E1.09.93·10.251.09.98-1.42-12.525.928020612.18  12.18  9.9819.46  6.9516:00:0015 min
Omega - O 10.73-0.67-5.91.011811.42  11.52  10.6315:46:3815 min
Pure - P 10.73-0.67-5.90.11110.73  10.73  10.7315:46:3815 min
Chi-X - X 9.95-1.45-12.71.9211412.20  12.20  9.9515:59:1515 min
CX2 - H 10.73-0.67-5.91.3151212.20  12.20  10.7315:46:3815 min
CXD - D 11.400.4328    Jun 0315 min
TriAct - M 11.403.83992    15 min
CS2 - S 10.63-0.77-6.80.11210.63  10.63  10.6315:42:3115 min

Recent Trades - Last 10 of 363
Time ETExPriceChangeVolumeBuyerSellerMarkers
16:00:00E9.98-1.420301 NEO Buy301 NEO BuyZ
15:59:45M9.93-1.47580 National Bank1 AnonymousE
15:59:34E9.98-1.422007 TD Sec79 CIBCK
15:59:34E9.98-1.421007 TD Sec79 CIBCK
15:59:34E9.98-1.421007 TD Sec79 CIBCK
15:59:15X9.95-1.4510080 National Bank79 CIBCK
15:58:40M9.97-1.43280 National Bank80 National BankE
15:58:33E10.00-1.401007 TD Sec79 CIBCK
15:58:33E10.00-1.402007 TD Sec79 CIBCK
15:58:29E10.00-1.401007 TD Sec79 CIBCK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-07-01 09:50C:CYBN11.40News ReleaseGlobal Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032
2025-06-30 22:03C:CYBN11.40News ReleaseCybin Reports Fiscal Year 2025 Financial Results and Recent Business Highlights
2025-06-30 21:54C:CYBN11.40SEDAR Annual Information FormSEDAR Annual Information Form
2025-06-30 21:54C:CYBN11.40SEDAR MD & ASEDAR MD & A
2025-06-30 21:49C:CYBN11.40SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2025-06-30 21:27C:CYBN11.40News ReleaseCybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible Debentures
2025-06-13 16:51C:CYBN11.20News ReleaseCybin talks partnerships, regulatory signals
2025-06-11 07:30C:CYBN12.20News ReleaseCybin to Participate in the 2025 Psychedelic Science Conference
2025-06-03 17:02C:CYBN11.25News ReleaseCybin receives U.S. patent for CYB004 DMT program
2025-05-20 12:33C:CYBN11.80News ReleaseCybin hears FDA pushing for psychedelic therapeutics
2025-05-15 16:49C:CYBN11.80News ReleaseCybin hires Thermo Fisher for phase 3 supply of CYB003
2025-05-14 07:30C:CYBN11.80News ReleaseCybin to Participate in the Alliance Global Partners Healthcare Company Showcase
2025-05-08 17:29C:CYBNNews ReleaseCybin receives U.S. patent for its CYB003 program
2025-05-01 07:30C:CYBN11.80News ReleaseCybin to Participate at the 28th Annual Milken Institute Global Conference
2025-04-23 07:30C:CYBN11.80News ReleaseCybin Announces Additional Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Phase 3 Program Evaluating CYB003
2025-04-21 17:01C:CYBN11.80News ReleaseCybin forms partnership with Osmind
2025-02-10 21:48C:CYBN13.25News ReleaseCybin Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights
2025-02-10 20:55C:CYBN13.25SEDAR Interim MD & ASEDAR Interim MD & A
2025-02-10 20:49C:CYBN13.25SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-01-15 18:18C:CYBN13.10News ReleaseCybin launches partnership agreement with Segal Trials